U-50488
U-50488 is a drug which acts as a highly selective kappa-opioid agonist. It has analgesic effects and can cause dysphoria and hallucinations. It was discovered in 1976 by the Upjohn company.
Chemistry[edit | edit source]
U-50488 is a structurally novel, selective kappa opioid receptor agonist. The chemical name of U-50488 is trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide.
Pharmacology[edit | edit source]
U-50488 has been found to act as a highly selective κ-opioid agonist, but without any significant activity at the μ- or δ-opioid receptors. It has been used in scientific research for its analgesic effects and as a tool to better understand the function of kappa opioid receptors.
Effects[edit | edit source]
The effects of U-50488 include analgesia, diuresis, and sedation. It can also cause dysphoria and hallucinations. The dysphoric and hallucinogenic effects are thought to be due to the kappa opioid receptor's role in the regulation of perception and mood.
See also[edit | edit source]
U-50488 Resources | ||
---|---|---|
|
|
|
Find a healthcare provider anywhere in the world quickly and easily!
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
WikiMD is the world's largest, free medical and wellness encyclopedia edited only by professionals. Advertise!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD